Selenium Enriched Plant Material for Chemoprevention

Information

  • Research Project
  • 6513470
  • ApplicationId
    6513470
  • Core Project Number
    R42CA080444
  • Full Project Number
    5R42CA080444-03
  • Serial Number
    80444
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2001 - 23 years ago
  • Project End Date
    12/31/2003 - 21 years ago
  • Program Officer Name
    PODSKALNY, JUDITH M.
  • Budget Start Date
    6/1/2002 - 22 years ago
  • Budget End Date
    12/31/2003 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    3
  • Suffix
  • Award Notice Date
    6/20/2002 - 22 years ago
Organizations

Selenium Enriched Plant Material for Chemoprevention

DESCRIPTION (Scanned from the Applicant's Abstract): Selenium may play a significant role in cancer prevention. Dietary selenium aids in preventing several types of carcinomas including lung, prostate, and colon. The potency of Se varies with its chemical form. The most effective compounds are rapidly and quantitatively transformed by the body, such as Se-methylselenocysteine, one of the most effective anti-carcinogenic Se-compounds. An inexpensive way to provide dietary Se would be to enrich certain foodstuffs with Se, preferably in the form of Se-methylselenocysteine. We propose to create this type of product by engineering crop plants to accumulate Se -methylselenocysteine. Phase I studies have established the feasibility of altering selenium metabolism in Arabidopsis thaliana by overexpressing ATP sulfurylase, resulting in more efficient assimilation of selenate. Selenocysteine methyltransferase from A. bisulcatus was also expressed in A. thaliana. Further improvements in the ability of these plants to take up and transform selenate involve cloning additional genes involved in Se accumulation. Based on results of the Phase I research, genes involved in Se uptake in the roots and chemical reduction of selenate to selenite in the tissues will be targeted. We will transfer these genes into Brassica juncea, the Indian mustard plants, to produce a commercially viable high Se-methylselenocysteine plant product. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R42
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    216727
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
  • Funding ICs
    NCI:216727\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NUCYCLE THERAPY, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    HILLSIDE
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07205
  • Organization District
    UNITED STATES